News

The Lancet2d
Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
eDepartment of Medicine, University of California, San Diego, CA, USA fDivision of Gastroenterology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX, ...
‘Significant Strides': Panel Studying Respondents' Mental Health Needs Recommends Outpatient Treatment Program
The New York Unified Court System's 49-member Judicial Task Force on Mental Illness also recommends the launch of a yearlong ...